luteinized unruptured follicles syndrome
Conditions
Interventions
Experimental Group:Double trigger when triggered
Control Group:HCG trigger when triggered
Sponsors
Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1.Women aged 20-38; 2.Patients who are planning to undergo OI/OI+IUI treatment; 3.Patients who meet the diagnostic criteria for LUFS and have received other treatments but have not achieved satisfactory results; 4.Patients who are willing to accept the treatment plan of this study and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1.Diagnosed uterine cavity abnormalities, including uterine malformation, uterine cavity adhesions, type 0-2 fibroids in accordance with FIGO uterine fibroid classification, or type 3-5 fibroids with a diameter greater than 5 cm, etc. 2.Patients with a history of tuberculosis or immune system diseases such as systemic lupus erythematosus; 3.Patients who have used NSAIDs for a long time or continuously for more than 3 months; 4.Ultrasound confirmed that there was hydrosalpinx and it was not treated; 5.After sperm washing, the husband has less than 10 million sperm with forward motility or the sperm morphology rate is less than 1%. 6.Exclude thyroid dysfunction, congenital adrenal hyperplasia, hypertension, diabetes, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ovulation rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Live birth rate;Pregnancy rate; | — |
Countries
China
Contacts
Public ContactQin Huisi
Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region
Outcome results
None listed